-
The Lancet: Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering
16 Apr 2024 01:43 GMT
… my job when I started chemotherapy as I could not cope … Eli Lilly; honoraria from Roche, Myriad
Genetics, and Novartis; and support for …
-
Kiyatec strengthens its leadership position with the addition of Mark Capone, former CEO of Myriad Genetics, as Strategic Advisor
21 Nov 2023 15:16 GMT
… Mark Capone, former CEO of Myriad Genetics, as Strategic Advisor. (Photo: Business … his 17-year career at Myriad Genetics, Mr. Capone transformed the … And for biopharmaceutical companies developing chemotherapeutics, targeted therapies, and immuno-oncology …
-
QIAGEN und Myriad Genetics schließen Partnerschaft und treiben Entwicklung von Begleitdiagnostika für Krebs voran
26 Oct 2023 12:00 GMT
… President of Companion Diagnostics bei Myriad Genetics. „Wir bauen die globale … erhöht, die mit einer Chemotherapie behandelt werden. MRD ist … Onkologieprodukten vorantreiben wird. Über Myriad Genetics Myriad Genetics ist ein führendes Unternehmen für …
-
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
26 Oct 2023 12:00 GMT
… ; Frankfurt Prime Standard: QIA) and Myriad Genetics (NASDAQ: MYGN) today announced a … ability for cancers treated with chemotherapy. MRD is a highly complex … portfolio of oncology products. About Myriad Genetics Myriad Genetics is a leading genetic testing …
-
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
26 Oct 2023 12:00 GMT
… ; Frankfurt Prime Standard: QIA) and Myriad Genetics (NASDAQ: MYGN) today announced a … ability for cancers treated with chemotherapy. MRD is a highly complex … portfolio of oncology products. About Myriad Genetics Myriad Genetics is a leading genetic testing …
-
Myriad Genetics and MSK to assess MRD testing in breast cancer patients
19 Sep 2023 19:33 GMT
Myriad Genetics has formed a collaboration with … testing in association with chemotherapy treatment response.
Myriad Genetics chief scientific officer Dale …
-
Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer
18 Sep 2023 12:00 GMT
… association of MRD testing with chemotherapy treatment response. “Several … Muzzey, chief scientific officer, Myriad Genetics. “Because we use whole … through survivorship monitoring. About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
New Products Posted to GenomeWeb: LabCorp, BostonGene, Seer, Myriad Genetics, More
02 Jun 2023 19:59 GMT
… of proteomics experiments.
Myriad Genetics Folate Receptor Alpha Biomarker
Myriad Genetics said that it … and resistant to platinum-based chemotherapy. FRα is a newly recommended …
-
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer
24 May 2023 20:05 GMT
… and resistant to platinum-based chemotherapy. FRα is a newly … , general manager of Oncology, Myriad Genetics. About Myriad Genetics
Myriad Genetics is a leading genetic testing … registered trademarks or trademarks of Myriad Genetics, Inc. All third-party …
-
Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing
07 Feb 2023 12:15 GMT
… could therefore safely avoid adjuvant chemotherapy as part of their … for several cancer types.
About Myriad Genetics
Myriad Genetics is a leading genetic testing … or registered trademarks of Myriad Genetics, Inc. © 2022 Myriad Genetics, Inc. All rights …